PubMed

Allelic depletion of grem1 attenuates diabetic kidney disease.

Roxburgh SA, Kattla JJ, Curran SP, O'Meara YM, Pollock CA, Goldschmeding R, Godson C, Martin F, Brazil DP.

Diabetes. 2009 Jul;58(7):1641-50. Epub 2009 Apr 28.PMID: 19401426 [PubMed - indexed for MEDLINE]Related articlesFree article

CTGF inhibits BMP-7 signaling in diabetic nephropathy.

Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, Bovenschen N, Li Z, Xu L, Oliver N, Aten J, Joles JA, Vial C, Brandan E, Lyons KM, Goldschmeding R.

J Am Soc Nephrol. 2008 Nov;19(11):2098-107. Epub 2008 Jul 16.PMID: 18632843 [PubMed - indexed for MEDLINE]Related articlesFree article

Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.

Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1657-65. Epub 2007 Sep 5.PMID: 17804483 [PubMed - indexed for MEDLINE]Related articlesFree article

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.

Tan Y, Keum JS, Wang B, McHenry MB, Lipsitz SR, Jaffa AA.

Am J Physiol Renal Physiol. 2007 Oct;293(4):F1026-35. Epub 2007 Jun 27.PMID: 17596525 [PubMed - indexed for MEDLINE]Related articlesFree article

Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.

Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.

Diabetes. 2007 Feb;56(2):346-54.PMID: 17259378 [PubMed - indexed for MEDLINE]Related articlesFree article

Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R.

Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. Epub 2005 Dec 27.PMID: 16380465 [PubMed - indexed for MEDLINE]Related articlesFree article

Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

Wang S, Denichilo M, Brubaker C, Hirschberg R.

Kidney Int. 2001 Jul;60(1):96-105.PMID: 11422741 [PubMed - indexed for MEDLINE]Related articlesFree article

Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes.

Hammad SM, Hazen-Martin DJ, Sohn M, Eldridge L, Powell-Braxton L, Won W, Lyons TJ.

Kidney Blood Press Res. 2003;26(5-6):351-61.PMID: 14610340 [PubMed - indexed for MEDLINE]Related articles

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy.

Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S.

Biochem Biophys Res Commun. 2003 Jun 13;305(4):1002-7.PMID: 12767930 [PubMed - indexed for MEDLINE]Related articles

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.

Guha M, Xu ZG, Tung D, Lanting L, Natarajan R.

FASEB J. 2007 Oct;21(12):3355-68. Epub 2007 Jun 6.PMID: 17554073 [PubMed - indexed for MEDLINE]Related articlesFree article

Kidney involvement in a nongenetic rat model of type 2 diabetes.

Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE.

Kidney Int. 2005 Dec;68(6):2562-71.PMID: 16316331 [PubMed - indexed for MEDLINE]Related articles

Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.

Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM.

J Diabetes Complications. 2008 Jul-Aug;22(4):284-94. Epub 2008 Apr 16.PMID: 18413184 [PubMed - indexed for MEDLINE]Related articles

Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

Park CW, Kim HW, Ko SH, Chung HW, Lim SW, Yang CW, Chang YS, Sugawara A, Guan Y, Breyer MD.

Diabetes. 2006 Apr;55(4):885-93.PMID: 16567507 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.

Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F819-29. Epub 2009 Feb 11.PMID: 19211686 [PubMed - indexed for MEDLINE]Related articles

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.

Awad AS, Huang L, Ye H, Duong ET, Bolton WK, Linden J, Okusa MD.

Am J Physiol Renal Physiol. 2006 Apr;290(4):F828-37. Epub 2005 Dec 6.PMID: 16332931 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of fibrillin-1 in hypertensive and diabetic glomerular disease.

Hartner A, Schaefer L, Porst M, Cordasic N, Gabriel A, Klanke B, Reinhardt DP, Hilgers KF.

Am J Physiol Renal Physiol. 2006 Jun;290(6):F1329-36. Epub 2005 Dec 27.PMID: 16380460 [PubMed - indexed for MEDLINE]Related articlesFree article

Lack of type VIII collagen in mice ameliorates diabetic nephropathy.

Hopfer U, Hopfer H, Meyer-Schwesinger C, Loeffler I, Fukai N, Olsen BR, Stahl RA, Wolf G.

Diabetes. 2009 Jul;58(7):1672-81. Epub 2009 Apr 28.PMID: 19401424 [PubMed - indexed for MEDLINE]Related articlesFree article

Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.

Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK.

Endocrinology. 2006 Nov;147(11):5363-73. Epub 2006 Aug 10.PMID: 16901964 [PubMed - indexed for MEDLINE]Related articlesFree article